How to Decide Exactly Where to Get Fillers and Botox
Your forehead isn't the only spot you can get an injectable. Here's what you need to know about filler and Botox injection sites — both well-established and newly available, according to Shape.
Category: Injectibles
Injectibles
Popular
Injectibles
Latest
Survey Finds Major Shortcomings in UK Cosmetic Injection Safety
The study reports that many patients do not receive proper consent forms, information on complications, or aftercare instructions.
All
Latest
BTL Moves to Block Distribution of Competing Facial Device in Europe
BTL Group has filed a patent infringement lawsuit in the Unified Patent Court against Lexter Microelectronic Engineering Systems, the maker of WonderFace.
FDA Greenlights New Hyaluronic Acid Dermal Filler, Introducing Brand to HA Filler Market
The HA filler is designed to deliver natural-looking results with high HA content, consistent gel distribution, and a predictable injection force and swelling profile.
Read More
Allergan Rolls Out National Campaign for BOTOX Cosmetic Featuring Everyday Patients
Allergan Aesthetics has launched “The One & Only,” its largest marketing campaign for BOTOX Cosmetic, featuring real patients and emphasizing self-expression.
Read More
Revance Replaces Lidocaine with Mepivacaine in RHA Filler Line
Revance announces the U.S. launch of the Teoxane RHA Collection with mepivacaine, replacing lidocaine as the anesthetic in its dermal filler products.
Read More
Evolus Reports Positive Results for Mid-Face Filler Evolysse Sculpt
Evolus has reported that its mid-face filler Evolysse Sculpt outperformed Restylane-Lyft in a pivotal U.S. trial.
Read More
Evolus Advances Mid-Face Filler Toward FDA Approval
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
Read More
Galderma Reports Positive Results for Facial Volume Loss Tied to Medication-Driven Weight Loss
The phase IV trial evaluated outcomes of Sculptra plus Restylane Lyft or Contour in patients with facial volume loss due to weight loss medications.
Read More
Patient Perspective as Clinical Data: Dr Steven Dayan on PROs and Aesthetic Outcomes
Dr Steven Dayan discusses how patient-reported outcomes (PROs) are shaping clinical research, regulatory standards, and patient care in aesthetic medicine.
Read More
Skinvive by Juvéderm Targets Neck Lines in New FDA Filing
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
Read More
Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
Read More
Health Canada Approves Radiesse for Décolleté Wrinkles
Regulatory approval allows clinicians to use the biostimulatory filler to treat moderate wrinkles in the chest area.
Read More
Where Non-Surgical Aesthetic Spending Is Headed: Inside the $17.5 Billion Aesthetic Shift
Guidepoint Qsight’s Erik Haines breaks down the drivers behind 2024’s $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry.
Read More
How Evolysse Could Change the HA Filler Market: Insights from Dr Rami Batniji
Dr Rami Batniji discusses how Evolysse’s cold technology manufacturing process may offer clinical advantages over traditional hyaluronic acid fillers.
Read More
Understanding the Rise in Male Facial Plastic Surgery: Insights from AAFPRS President Patrick Byrne
AAFPRS President Dr. Patrick Byrne discusses the growing interest in facial cosmetic procedures among male patients and how private practices can adapt to meet their evolving needs.
Read More
New Revanesse Renew+ Skin-boosting Injection Debuts in Canada
The product is designed to provide long-lasting hydration to improve skin quality from the inside out.
Read More
New Short-Term Botox-Like Treatment Moves Closer to FDA Review
The neurotoxin is characterized by a rapid onset of action as early as eight hours after administration and a shorter duration of effect of two to three weeks.
Read More